SEARCH

SEARCH BY CITATION

References

  • 1
    Poynard T, Yuen MF, Ratziu V, Lung Lai C. Viral hepatitis C. Lancet 2003; 362: 20952100.
  • 2
    Bonny C, Rayssiguier R, Ughetto S, Aublet-Cuvelier B, Baranger J, Blanchet G, et al. Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region. Gastroenterol Clin Biol 2003; 27: 10211025.
  • 3
    Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003; 38: 14491457.
  • 4
    Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pizie D, et al. Sampling variability and the influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523525.
  • 5
    Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 26142618.
    Direct Link:
  • 6
    Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WH. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 1971; 16: 10821086.
  • 7
    Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139: 667669.
  • 8
    Sandrin L, Tanter M, Gennisson JL, Catheline S, Fink M. Shear elasticity probe for soft tissues with 1D transient elastography. Ultrason Ferroelectr Freq Control 2002; 49: 436446.
  • 9
    Bedossa P, Poynard T. An algorithm for grading of activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289293.
  • 10
    Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 17051713.
  • 11
    The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. HEPATOLOGY 1994; 20: 1520.
  • 12
    Hanley JA, McNeil BJ. The meaning and use of the area under the Receiver Operating Characteristic (ROC) curve. Radiology 1982; 143: 2936.
  • 13
    Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839843.
  • 14
    Steyerberg EW, Harrell FE Jr, Borsboom GJJM, Eijkemans MJC, Vergouwe Y, Habbemia JDF. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54: 774781.
  • 15
    Fung YC. Biomechanical Properties of Living Tissues. New York: Springer Verlag, 1981.
  • 16
    Yeh WC, Li PC, Jeng YM, Hsu HC, Kuo PL, Li ML, et al. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol 2002; 28: 467474.
  • 17
    Saadeh S, Cammel G, Carey WD, Youmossi Z, Barns D, Easley K. The role of liver biopsy in chronic hepatitis C. HEPATOLOGY 2001; 33: 196200.
  • 18
    Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000; 14: 54348.
  • 19
    Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495500.
  • 20
    Batts KP, Ludwig J. Chronic hepatitis an update on terminology and reporting. Am J Surg Pathol 1995; 19: 14091417.
  • 21
    Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003; 38: 427432.
  • 22
    Teare JP, Sherman D, Greenfield SM, Simpson J, Bray G, Catteral AP, et al. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Lancet 1993; 342: 895898.
  • 23
    Gabrielli GB, Capra F, Casaril M, Squarzoni S, Tognella P, Dagradi R, et al. Serum laminin and type III procollagen in chronic hepatitis C: diagnostic value in the assessment of disease activity and fibrosis. Clin Chim Acta. 1997; 265: 2131.
  • 24
    Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen aminoterminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42: 558563.
  • 25
    Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. Alpha-2-macroglobulin and hepatic fibrosis: diagnostic interest. Dig Dis Sci 1994; 39: 24262432.
  • 26
    Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepatol 1998; 5: 187192.
  • 27
    Wai CT, Greenson JK, Fontana RJ, Kalfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. HEPATOLOGY 2003; 38: 518526.
  • 28
    Forns X, Ampurdanès S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. HEPATOLOGY 2003; 36: 986992.
  • 29
    Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 10691075.
  • 30
    Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003; 49: 450454.
  • 31
    Halfon P, Bourliere M, Deydier R, Portal I, Renou C, Bertrand JJ, et al. Independent prospective multicenter validation of biochemical markers (Fibrotest-Actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C. 54th Annual Meeting of the AASLD, HEPATOLOGY 2003; 38: 188A.